Sep 01, 09:07
50% of moneycontrol users recommend buying Surya Pharma.
What's your call on Surya Pharma today?
Read 6 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2962.30||0.38||2969.00||2286.80||50,458.35|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Jindal PolyFilms Recommended on May 27th 2014
Recommended price 177.00 | Peak from reco 320.85 81.27%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Surya Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 31.83 crore.The company has reported a standalone sales of Rs 0.57 crore and a Net Loss of Rs -867.83 crore for the quarter ended Dec 2013.
The company management includes Rajiv Goyal - Chairman & Managing Director, Alka Goyal - Executive Director, Subhash Chander Marwaha - Nominee Director, Jasvinder Singh - Addnl. & Ind.Director.
It is listed on the BSE with a BSE Code of 532516 and the NSE with an NSE Code of SURYAPHARM.
Its Registered office is at 1956, 1st Floor, Bhagirath Place,,Chandni Chowk New Delhi,Delhi - 110006.
Their Registrars are Bigshare Services Pvt. Ltd.